- Home
- SDOT vs PMCB Comparison
SDOT vs PMCB Comparison
Compare SDOT & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDOT
- PMCB
- Stock Information
- Founded
- SDOT 2014
- PMCB 1996
- Country
- SDOT United States
- PMCB United States
- Employees
- SDOT N/A
- PMCB N/A
- Industry
- SDOT Restaurants
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SDOT Consumer Discretionary
- PMCB Health Care
- Exchange
- SDOT Nasdaq
- PMCB Nasdaq
- Market Cap
- SDOT 8.0M
- PMCB 6.6M
- IPO Year
- SDOT 2020
- PMCB N/A
- Fundamental
- Price
- SDOT $7.60
- PMCB $0.93
- Analyst Decision
- SDOT
- PMCB
- Analyst Count
- SDOT 0
- PMCB 0
- Target Price
- SDOT N/A
- PMCB N/A
- AVG Volume (30 Days)
- SDOT 30.1K
- PMCB 106.5K
- Earning Date
- SDOT 11-11-2025
- PMCB 09-15-2025
- Dividend Yield
- SDOT N/A
- PMCB N/A
- EPS Growth
- SDOT N/A
- PMCB N/A
- EPS
- SDOT 6.14
- PMCB 0.01
- Revenue
- SDOT $667,695,000.00
- PMCB N/A
- Revenue This Year
- SDOT $12.76
- PMCB N/A
- Revenue Next Year
- SDOT $5.54
- PMCB N/A
- P/E Ratio
- SDOT $1.26
- PMCB $160.47
- Revenue Growth
- SDOT 7.00
- PMCB N/A
- 52 Week Low
- SDOT $7.00
- PMCB $0.80
- 52 Week High
- SDOT $57.00
- PMCB $2.42
- Technical
- Relative Strength Index (RSI)
- SDOT 53.47
- PMCB 44.27
- Support Level
- SDOT $7.00
- PMCB $1.00
- Resistance Level
- SDOT $8.25
- PMCB $1.08
- Average True Range (ATR)
- SDOT 0.48
- PMCB 0.08
- MACD
- SDOT 0.41
- PMCB -0.00
- Stochastic Oscillator
- SDOT 66.85
- PMCB 2.95
About SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.